Skip to main content

View full-text article in PMC

. 2023 May 11;9(1):1–7. doi: 10.1136/svn-2022-001499

Table 5.

The association between antithrombotics and stroke risk*

Antithrombotic type	Ischaemic stroke				Haemorrhagic stroke
	No (N=7862)	Yes (N=448)	aHR* (95% CI)	P value	No (N=8195) N (%)	Yes (N=115) N (%)	aHR* (95% CI)	P value
	N (%)	N (%)	aHR* (95% CI)	P value	No (N=8195) N (%)	Yes (N=115) N (%)	aHR* (95% CI)	P value
Antiplatelet	1741 (22.1)	169 (37.7)	2.02 (1.66 to 2.45)	<0.001	1947 (23.8)	40 (34.8)	1.74 (1.18 to 2.57)	0.005
Anticoagulant	238 (3.0)	33 (7.4)	2.56 (1.79 to 3.66)	<0.001	278 (3.4)	7 (6.1)	2.00 (0.91 to 4.20)	0.086
Antithrombotic	1862 (23.7)	180† (40.2)	2.06 (1.70 to 2.49)	<0.001	2080 (25.4)	43‡ (37.4)	1.79 (1.22 to 2.63)	0.003

*Adjusted for age, gender, CCI, and urbanisation level.

†In total, 22 patients used both anticoagulants and antiplatelets.

‡Four patients used both anticoagulants and antiplatelets.